The proposed bill establishes the "Diabetes Prevention and Obesity Treatment Act" by creating a new section, 385.2035, in the Florida Statutes. This legislation mandates that beginning January 1, 2026, the Agency for Health Care Administration (AHCA) must provide Medicaid coverage for diabetes prevention programs and certain treatments for obesity, provided that recipients meet specific eligibility criteria. The bill defines key terms related to diabetes prevention and obesity treatment, including "diabetes prevention program," "FDA-approved obesity medication," and "intensive health behavioral and lifestyle treatment." It also outlines the types of obesity treatments that will be covered, such as metabolic and bariatric surgery and FDA-approved medications, while ensuring that coverage criteria for these medications are not more restrictive than FDA indications.

Additionally, the bill requires the AHCA to adopt rules for implementation and to notify Medicaid recipients about the availability of these services. The agency is also authorized to seek federal approval through a state plan amendment or Medicaid waiver if necessary to implement the provisions of the act. The effective date for this legislation is set for July 1, 2025.